Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate-Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Publication date: 2024

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Publication Year: 2024

Authors & Co-authors:  Hoffman Risa M RM Brummel Sean S Ziemba Lauren L Chinula Lameck L McCarthy Katie K Fairlie Lee L Jean-Philippe Patrick P Chakhtoura Nahida N Johnston Ben B Krotje Chelsea C

Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial.

Journal: PloS one

Publication date: 2015

Journal: PloS one

Publication Year: 2015

Authors & Co-authors:  Safren Steven A SA Biello Katie B KB Smeaton Laura L Mimiaga Matthew J MJ Walawander Ann A Lama Javier R JR Rana Aadia A Nyirenda Mulinda M Kayoyo Virginia M VM Samaneka Wadzanai W

Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study.

Journal: The lancet. HIV

Publication date: 2021

Journal: The lancet. HIV

Publication Year: 2021

Authors & Co-authors:  Ruel Theodore D TD Capparelli Edmund V EV Tierney Camlin C Nelson Bryan S BS Coletti Anne A Bryson Yvonne Y Cotton Mark F MF Spector Stephen A SA Mirochnick Mark M LeBlanc Rebecca R

Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study.

Journal: The lancet. HIV

Publication date: 2022

Journal: The lancet. HIV

Publication Year: 2022

Authors & Co-authors:  Bekker Adrie A Capparelli Edmund V EV Violari Avy A Cotton Mark F MF Cababasay Mae M Wang Jiajia J Mathiba Ruth R Wiesner Lubbe L Wiznia Andrew A Samson Pearl P

Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial.

Journal: The lancet. HIV

Publication date: 2019

Journal: The lancet. HIV

Publication Year: 2019

Authors & Co-authors:  Nachman Alvero Teppler Homony Rodgers Graham Fenton Frenkel Browning Hazra

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial.

Journal: Lancet (London, England)

Publication date: 2021

Journal: Lancet (London, England)

Publication Year: 2021

Authors & Co-authors:  Lockman Brummel Ziemba Stranix-Chibanda McCarthy Coletti Jean-Philippe Johnston Krotje Fairlie

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial.

Journal: The lancet. HIV

Publication date: 2023

Journal: The lancet. HIV

Publication Year: 2023

Authors & Co-authors:  Chinula Ziemba Brummel McCarthy Coletti Krotje Johnston Knowles Moyo Stranix-Chibanda

Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study.

Journal: The lancet. HIV

Publication date: 2023

Journal: The lancet. HIV

Publication Year: 2023

Authors & Co-authors:  Brooks Kiser Ziemba Ward Rani Cressey Masheto Cassim Deville Ponatshego

How well do neural signatures of resting-state EEG detect consciousness? A large-scale clinical study.

Journal: Human brain mapping

Publication date: 2024

Journal: Human brain mapping

Publication Year: 2024

Authors & Co-authors:  Ma Qi Xu Weng Yu Sun Yu Wu Gao Li

The volume of gray matter mediates the relationship between glucolipid metabolism and neurocognition in first-episode, drug-naïve patients with schizophrenia.

Journal: Journal of psychiatric research

Publication date: 2024

Journal: Journal of psychiatric research

Publication Year: 2024

Authors & Co-authors:  Cao Meng Zhang Deng Guo Li Li

Antiretroviral therapy and vaginally administered contraceptive hormones: a three-arm, pharmacokinetic study.

Journal: The lancet. HIV

Publication date: 2020

Journal: The lancet. HIV

Publication Year: 2020

Authors & Co-authors:  Scarsi Cramer Rosenkranz Aweeka Berzins Coombs Coughlin Moran Zorrilla Akelo

Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1-2 trial.

Journal: The lancet. HIV

Publication date: 2022

Journal: The lancet. HIV

Publication Year: 2022

Authors & Co-authors:  Ruel Acosta Liu Gray George Montañez Popson Buchanan Bartlett Dayton

HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study.

Journal: The lancet. HIV

Publication date: 2023

Journal: The lancet. HIV

Publication Year: 2023

Authors & Co-authors:  Chadwick Jean-Philippe Yin Majji Carrington Reding Korutaro Kekitiinwa Nicodimus Stranix-Chibanda